STK31 maintains the undifferentiated state of colon cancer cells

Kin Lam Fok1, Chin Man Chung, Shao Qiong Yi

  • 1Epithelial Cell Biology Research Centre The Chinese University of Hong Kong Hong Kong SAR.

Carcinogenesis
|July 26, 2012
PubMed

Insights

Serine/threonine kinase 31 (STK31) controls colon cancer cell differentiation and tumorigenicity. Targeting STK31 may offer a new therapeutic strategy for colon cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Altered expression of serine/threonine kinase (STK) family members is common in human cancers.
  • The specific roles of STKs, including STK31, in cancer development are not fully understood.

Purpose of the Study:

  • To investigate the role of STK31 in colon cancer.
  • To determine the functional significance of STK31 in colon cancer cell differentiation and tumorigenicity.

Main Methods:

  • Analysis of STK31 expression in colon cancer tissues.
  • In vitro and in vivo experiments involving STK31 knockdown and overexpression.
  • Assessment of colon cancer cell differentiation and tumorigenicity.
  • Genome microarray analysis to identify gene expression changes.
  • Site-directed mutagenesis to delete the STK domain of STK31.

Main Results:

  • STK31 is robustly and heterogeneously expressed in colon cancer tissues.
  • STK31 modulates colon cancer cell differentiation; its knockdown induces differentiation, while overexpression inhibits it.
  • The kinase domain of STK31 is essential for its inhibitory effect on differentiation.
  • STK31 knockdown significantly suppresses colon cancer cell tumorigenicity in vitro and in vivo.
  • STK31 knockdown alters the expression of genes involved in germ cell and cancer differentiation.

Conclusions:

  • STK31 plays a critical role in controlling the differentiation state of colon cancer cells, dependent on its kinase domain.
  • These findings suggest STK31 as a potential therapeutic target for colon cancer, potentially by modulating cancer cell differentiation.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...